VITAL THERAPIES INC (57)

Browse by Contract Category

Contracts

Fourth Addendum, dated January 16, 2023, to Service Agreement between Immunic AG and Dr. Hella Kohlhof (Filed With SEC on January 20, 2023)
Addendum No. 4 to Employment Agreement, dated December 28, 2022, between Immunic, Inc. and Duane Nash (Filed With SEC on December 30, 2022)
Description of Registrant's Securities (Filed With SEC on November 3, 2022)
Securities Purchase Agreement, dated October 10, 2022, by and among the Company and the Purchasers (Filed With SEC on October 11, 2022)
Option and License Agreement, dated September 27, 2018, between Immunic AG and Daiichi Sankyo Company, Limited (Filed With SEC on July 17, 2019)
Lease Assignment Agreement by and between ViaCyte, Inc. and Vital Therapies, Inc (Filed With SEC on March 19, 2019)
Fourth Addendum, dated January 16, 2023, to Service Agreement between Immunic AG and Dr. Andreas Muehler (Filed With SEC on January 20, 2023)
Fourth Addendum, dated January 16, 2023, to Service Agreement between Immunic AG and Dr. Daniel Vitt (Filed With SEC on January 20, 2023)
Form of Pre-Funded Warrant (Filed With SEC on October 11, 2022)
Description of Registrant's Securities (Filed With SEC on August 4, 2022)
Description of Registrant's Securities (Filed With SEC on May 10, 2022)
Sales Agreement, dated as of May 2, 2022, between SVB Securities LLC and Immunic, Inc (Filed With SEC on May 2, 2022)
Addendum No. 3 to Employment Agreement, dated March 15, 2022, between Immunic, Inc. and Duane Nash (Filed With SEC on March 16, 2022)
Description of Registrant's Securities (Filed With SEC on February 24, 2022)
Third Addendum, dated January 5, 2022, to Service Agreement between Immunic AG and Dr. Daniel Vitt (Filed With SEC on January 10, 2022)
Third Addendum, dated January 5, 2022, to Service Agreement between Immunic AG and Dr. Andreas Muehler (Filed With SEC on January 10, 2022)
Third Addendum, dated January 5, 2022, to Service Agreement between Immunic AG and Dr. Hella Kohlhof (Filed With SEC on January 10, 2022)
Description of Registrant's Securities (Filed With SEC on November 4, 2021)
Employment Agreement, dated October 14, 2021, by Patrick Walsh and Immunic, Inc (Filed With SEC on October 15, 2021)
Description of Registrant's Securities (Filed With SEC on August 6, 2021)
Underwriting Agreement, dated July 15, 2021, by and between Immunic, Inc. and Piper Sandler & Co (Filed With SEC on July 19, 2021)
Employment Agreement, dated June 10, 2021, between Immunic, Inc. and Glenn Whaley (Filed With SEC on June 14, 2021)
Employment Agreement, dated June 10, 2021, between Immunic, Inc. and Dr. Andreas Muehler (Filed With SEC on June 14, 2021)
Second Addendum, dated June 10, 2021, to Service Agreement between Immunic AG and Dr. Andreas Muehler (Filed With SEC on June 14, 2021)
Second Addendum, dated June 10, 2021, to Service Agreement between Immunic AG and Dr. Daniel Vitt (Filed With SEC on June 14, 2021)
Description of Registrant's Securities (Filed With SEC on May 6, 2021)
Addendum No. 2 to Employment Agreement, dated April 15, 2021, between Immunic, Inc. and Duane Nash (Filed With SEC on April 19, 2021)
Settlement Agreement, dated March 31, 2021, between Immunic AG and 4SC AG (Filed With SEC on March 31, 2021)
Description of Registrant's Securities (Filed With SEC on February 26, 2021)
Sales Agreement, dated as of December 29, 2020, between SVB Leerink LLC and Immunic, Inc (Filed With SEC on January 4, 2021)
Amendment Letter, dated November 11, 2020 (Filed With SEC on November 13, 2020)
Addendum to Employment Agreement dated October 15, 2020, between Immunic, Inc. and Duane Nash (Filed With SEC on November 6, 2020)
Form of Guarantee Agreement between Immunic, Inc., Immunic AG and European Investment Bank (Filed With SEC on October 20, 2020)
Finance Contract, dated October 19, 2020, between Immunic, Inc., Immunic AG and European Investment Bank (Filed With SEC on October 20, 2020)
Underwriting Agreement, dated August 4, 2020, by and between Immunic, Inc. and SVB Leerink LLC (Filed With SEC on August 10, 2020)
Form of Securities Purchase Agreement, dated June 10, 2020, between the Company and the investors party thereto (Filed With SEC on June 12, 2020)
Placement Agency Agreement, dated June 10, 2020, between the Company and the Placement Agent (Filed With SEC on June 12, 2020)
Form of Securities Purchase Agreement, dated April 23, 2020, between the Company and the investors party thereto (Filed With SEC on April 27, 2020)
Letter Agreement, dated April 23, 2020, between the Company and the Placement Agent (Filed With SEC on April 27, 2020)
Employment Agreement dated April 17, 2020 (Filed With SEC on April 20, 2020)
Confidential Severance Agreement and Full and General Release dated April 17, 2020 (Filed With SEC on April 20, 2020)
Addendum, dated September 4, 2019, to Service Agreement between Immunic AG and Dr. Manfred Grppel (Filed With SEC on September 5, 2019)
Addendum, dated September 4, 2019, to Service Agreement between Immunic AG and Dr. Daniel Vitt (Filed With SEC on September 5, 2019)
Sales Agreement, dated as of July 17, 2019, between SVB Leerink LLC and Immunic, Inc (Filed With SEC on July 17, 2019)
Employment Agreement, dated as of July 15, 2019, by and between Sanjay Patel and Immunic, Inc (Filed With SEC on July 17, 2019)
Grppel Employment Agreement, dated as of August 26, 2016, by and between Dr. Manfred Grppel and Immunic AG (Filed With SEC on July 17, 2019)
Vitt Employment Agreement, dated as of March 23, 2016, by and between Dr. Daniel Vitt and Immunic AG (Filed With SEC on July 17, 2019)
Form of Indemnification Agreement (Filed With SEC on July 17, 2019)
Asset Purchase Agreement, dated May 13, 2016, between Immunic AG and 4SC AG (Filed With SEC on July 17, 2019)
Forms of Lock-Up Agreement (Filed With SEC on April 15, 2019)
Second Amendment to Asset Purchase Agreement between RH Cell Therapeutics Corp. and Vital Therapies, Inc. dated as of April 4, 2019 (Filed With SEC on April 10, 2019)
First Amendment to Asset Purchase Agreement between RH Cell Therapeutics Corp. and Vital Therapies, Inc. dated as of March 27, 2019 (Filed With SEC on April 10, 2019)
Asset Purchase Agreement by and between RH Cell Therapeutics Corp and Vital Therapies, Inc., dated March 13, 2019 (Filed With SEC on March 19, 2019)
Form of Amendment No. 1 to Change of Control and Severance Agreement (Filed With SEC on January 14, 2019)
Form of RSU Award Agreement under 2014 Equity Incentive Plan (Filed With SEC on January 14, 2019)
Exchange Agreement, dated as of January 6, 2019 by and among Vital Therapies, Inc., Immunic AG, and the shareholders of Immunic AG (Filed With SEC on January 7, 2019)
Investment and Subscription Agreement, dated as of January 6, 2019, among Immunic AG and its Shareholders (Filed With SEC on January 7, 2019)